Rothschild Investment LLC Genmab A/S Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Genmab A/S stock. As of the latest transaction made, Rothschild Investment LLC holds 683 shares of GMAB stock, worth $14,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
683
Previous 884
22.74%
Holding current value
$14,090
Previous $18.4 Million
27.51%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GMAB
# of Institutions
250Shares Held
61.4MCall Options Held
159KPut Options Held
38K-
Alliancebernstein L.P. New York, NY14.9MShares$308 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$105 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$63.8 Million0.01% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$58.1 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.81MShares$57.9 Million0.0% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.6B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...